
Drugs.com – Know More. Be Sure.
Search 24,000+ prescription, OTC, and natural medications. Peer-reviewed, clinically sourced drug information for safer, smarter health decisions.
Drugs & Medications A to Z - Drugs.com
A basic overview of each product is provided (including dosages, possible drug interactions, side effects and contraindications) along with safety and/or efficacy ratings.
Drug Interaction Checker - Find Unsafe Combinations
Nov 5, 2025 · Use Drugs.com’s Drug Interaction Checker, trusted by doctors and patients, to instantly review your meds for unsafe combinations.
Drug Information for Healthcare Professionals - Drugs.com
Access FDA-approved drug information, including AHFS DI Monographs, clinical pharmacology, and interaction data, tailored for healthcare professionals.
Drug Classification & Categories | Drugs.com
A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.
Health, Medical & Pharma News - Updated Daily - Drugs.com
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Pill Identifier - Quickly Find and ID your Drugs (with pictures)
Use our Pill Identifier tool to instantly match by imprint, shape, color, drug name, or NDC code. Access over 11,500 drug images, updated daily.
Which GLP-1 drug is best for weight loss? - Drugs.com
Jan 8, 2026 · As of mid-2025, the most effective GLP-1 drug for weight loss is tirzepatide (Mounjaro, Zepbound). Among the GLP-1 drugs currently available, tirzepatide and …
Drug Comparison Tool - Drugs.com
View side-by-side comparisons of medication uses, ratings & reviews, prices, FDA alerts, side effects, drug interactions, approval dates, classification, generic availability and more.
GLP-1 Drugs (Incretin Mimetics) - List of Brands & Generics
Oct 29, 2025 · Browse our GLP-1 drug list of incretin mimetics, including: Ozempic, Wegovy, and Rybelsus. Compare doses, side effects, user reviews, and more.